0000899243-20-018257.txt : 20200702 0000899243-20-018257.hdr.sgml : 20200702 20200702160227 ACCESSION NUMBER: 0000899243-20-018257 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christenson Johan CENTRAL INDEX KEY: 0001488771 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39344 FILM NUMBER: 201009198 MAIL ADDRESS: STREET 1: C/O ODLANDER, FREDRIKSON & CO. AB STREET 2: STRANDVAGEN 5B CITY: STOCKHOLM STATE: V7 ZIP: SE-114 51 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fusion Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001805890 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 270 LONGWOOD ROAD SOUTH CITY: HAMILTON STATE: A6 ZIP: L8P 0A6 BUSINESS PHONE: 289-799-0891 MAIL ADDRESS: STREET 1: 270 LONGWOOD ROAD SOUTH CITY: HAMILTON STATE: A6 ZIP: L8P 0A6 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-30 0 0001805890 Fusion Pharmaceuticals Inc. FUSN 0001488771 Christenson Johan C/O FUSION PHARMACEUTICALS INC. 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 ONTARIO, CANADA 1 0 0 0 Common Shares 2020-06-30 4 C 0 2497345 A 2497345 I See Footnote Common Shares 2020-06-30 4 C 0 1069902 A 3567247 I See Footnote Common Shares 2020-06-30 4 P 0 240000 17.00 A 3807247 I See Footnote Class A Preferred Exchangeable Shares 2020-06-30 4 C 0 13333333 D Common Shares 2497345 0 I See Footnote Class B Preferred Exchangeable Shares 2020-06-30 4 C 0 5712216 D Common Shares 1069902 0 I See Footnote Represents Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited. The Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited are redeemable into Class A Preferred Shares of the Issuer. Upon the closing of the Issuer's initial public offering, the Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemed into Class A Preferred Shares of the Issuer on a one-for-one basis, which subsequently converted into Common Shares of the Issuer on a one-for-5.339 basis. The Class A Preferred Exchangeable Shares have no expiration date. The securities are held directly by HealthCap VII, L.P. ("HCLP"). HealthCap VII GP SA ("HCSA") is the sole general partner of HCLP and has voting and investment control over the Shares and Preferred Stock held by HCLP. The reporting person has an indirect interest in HCSA and is an employee of HealthCap VII Advisor AB. The reporting person disclaims beneficial ownership of Shares and Preferred Stock held by HCLP except to the extent of any pecuniary interest therein. Represents Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited. The Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited are redeemable into Class B Preferred Shares of the Issuer. Upon the closing of the Issuer's initial public offering, the Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemed into Class B Preferred Shares of the Issuer on a one-for-one basis, which subsequently converted into Common Shares of the Issuer on a one-for-5.339 basis. The Class B Preferred Exchangeable Shares have no expiration date. /s/ John Crowley, Attorney-in-Fact 2020-07-02